A drug commonly used to treat asthma attacks is in short supply, increasing anxiety for patients who use it—and for pharmacies and health care facilities that provide it.
Albuterol sulfate inhalation solution has been in short supply since last fall, according to the U.S. Food and Drug Administration. A major manufacturer, Akorn, shut down in February, throwing a major wrench in the supply chain, according to the American Society of Health-System Pharmacists, which tracks drug shortages.
